3AGL

Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1039

Summary for 3AGL

• Entry DOI: 10.2210/pdb3agl/pdb
• Related: 3BWJ 3ag9 3agm
• Related PRD ID: PRD_000642
• Descriptor: cAMP-dependent protein kinase catalytic subunit alpha, (10R,20R,23R)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamido propyl)-10-methyl-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide (3 entities in total)
• Functional Keywords: pka, protein kinase a, bisubstrate inhibitor, arc-1039, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (human)
• Cellular location: Cytoplasm: P17612
• Total number of polymer chains: 2
• Total formula weight: 83557.10

Authors

Pflug, A.,Ragozina, J.,Uri, A.,Bossemeyer, D.,Engh, R.A. (deposition date: 2010-04-02, release date: 2010-09-01, Last modification date: 2024-10-30)

Primary citation

Pflug, A.,Rogozina, J.,Lavogina, D.,Enkvist, E.,Uri, A.,Engh, R.A.,Bossemeyer, D.
Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions.
J.Mol.Biol., 403:66-77, 2010

PubMed Abstract: Crystal structures of the catalytic subunit α of cAMP-dependent protein kinase (PKAc) with three adenosine analogue-oligoarginine conjugates (ARCs) are presented. The rationally designed ARCs include moieties that, in combination, target both the ATP- and the peptide-substrate-binding sites of PKAc, thereby taking advantage of high-affinity binding interactions offered by the ATP site while utilizing an additional mechanism for target specificity via binding to the peptide substrate site. The crystal structures demonstrate that, in accord with the previously reported bisubstrate character of ARCs, the inhibitors occupy both binding sites of PKAc. Further, they show new binding modes that may also apply to natural protein substrates of PKAc, which have not been revealed by previous crystallographic studies. The crystal structures described here contribute to the understanding of the substrate-binding patterns of PKAc and should also facilitate the design of inhibitors targeting PKAc and related protein kinases.

PubMed: 20732331
DOI: 10.1016/j.jmb.2010.08.028

Experimental method

X-RAY DIFFRACTION (2.1 Å)